The Unsolved Uninsured Problem
The new and remarkably large health care law, based on the vision of President Obama, will phase in quickly over the next several years. At its heart is the belief that every American should have…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 314Centene Puts Kentucky in Rear-view Mirror (CNC, WCG, CVH)
Medicaid insurance provider Centene Corp. (NYSE: CNC) today announced that it is exercising its contractual right to discontinue offering its Medicaid managed care in the state of Kentucky. The state and the company have…
Abbott Labs Q3 Profit Surges, but Revenues Slip
Abbott Laboratories (NYSE: ABT) said that third-quarter earnings surged, despite a slip in revenue, due to a double-digit decline in expenses. The health care company posted adjusted earnings per share (EPS) of $1.30 on…
Options Evaluation After FDA Panel Backing For NPS Pharma
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) may not yet have formal approval for its short bowel syndrome drug called Gattex, but it has at least received a panel back at the Food & Drug Administration.…
Johnson & Johnson Tops Earnings Expectations
Johnson & Johnson (NYSE: JNJ) reported fiscal third-quarter results before markets opened this morning. The health care giant posted earnings per share (EPS) of $1.25 on revenues of $17.1 billion. In the same period…
UnitedHealth Rises on Fewer Claims
UnitedHealth Group Inc. (NYSE: UNH) reported fiscal third-quarter results before markets opened this morning. The health insurer posted diluted earnings per share (EPS) of $1.50 on revenues of $27.3 billion. In the same period…
Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold short from Biogen Idec,…
Amarin Becomes A January 2013 Story on FDA Uncertainty
Amarin Corporation plc (NASDAQ: AMRN) is not exactly having a good day considering that its fish oil based drug for lowering triglycerides is not going to be a known event as soon as the company was…
Analysts in Defense of Edwards Lifesciences
Edwards Lifesciences Corp. (NYSE: EW) is the big disappointment of the day on Tuesday after the company lowered its TAVI sales guidance for the third quarter. What is so interesting is that some analysts are…
Coca-Cola, PepsiCo Join Calories Count Initiative
The American Beverage Association’s President Susan Neely said members of her group have agreed to what they call the Calories Count Vending Program. ABA officials said the plan is a: public-private partnership to provide…
Lilly Adds $1 Billion in Market Value from Alzheimer’s Study Data
Eli Lilly & Co. (NYSE: LLY) is confirming prior news showing that late-stage trial data analysis showed the the primary endpoints in cognitive and functional were not met in the two Phase 3, double-blind, placebo-controlled…
UnitedHealth Acquires Brazilian Insurer
U.S. health insurer UnitedHealth Group Inc. (NYSE: UNH) today announced that it is acquiring Brazilian health insurer Amil Participacoes S.A. for $4.3 billion in cash. The total deal is worth $4.9 billion, but UnitedHealth…
Bidding Starts for Allscripts (MDRX, BX, CG)
Electronic health-records provider Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) said late last month that it would explore a sale of the company. Bloomberg is reporting this morning that private equity firms Blackstone Group LP…
Cell Therapeutics Collapses on Secondary Offering
Biopharmaceutical firm Cell Therapeutics Inc. (NASDAQ: CTIC) announced a secondary offering this morning of 60,000 shares of its Series 17 preferred stock at a price of $1,000.00 per share: Each share of Series 17…
How Sarepta Got On The Map
Sarepta Therapeutics Inc. (NASDAQ: SRPT) is a company which many biohealth and biotech investors have likely never heard of. At least before today. How many shares rise more than 150% when there is not a…